Trials / Conditions / Recurrent Digestive System Neuroendocrine Tumor G1
Recurrent Digestive System Neuroendocrine Tumor G1
5 registered clinical trials studyying Recurrent Digestive System Neuroendocrine Tumor G1.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors NCT01841736 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by NCT01548482 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade N NCT01204476 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Isl NCT01010126 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer NCT00454363 | National Cancer Institute (NCI) | Phase 2 |